Similarly, T/T genotype and T allele of FGFR2 rs2981582 were found to increase the risk of early onset BC with OR of 2.40 (95% CI: 1.08–5.32) and 1.56 (95% CI: 1.05–2.32) respectively. This evidence concerns the gene FGFR2 and breast cancer.